Objective Given reports of neuropathogenesis following exposure to high dose MgSO4 in
preterm labor (J Pediatr 2002; 140: 540-6; J Perinatol 2005; 25: 101-7), as well as the report …

Objective: Use of antenatal magnesium sulfate (MgSO 4) may reduce cerebral palsy in
infants born very preterm. Low systemic blood flow in the first day in very preterm infants has …

Background In infants delivered preterm, magnesium sulfate reduces cerebral palsy in
survivors. The benefit of magnesium given remote from delivery is unclear. Objective Our …

Objective: Despite known racial disparities in obstetrics, as well as differences in
magnesium pharmacodynamics according to race, the effect of race/ethnicity in magnesium …

Effects and Safety of Magnesium Sulfate on Neuroprotection:... : Medicine Effects and Safety of
Magnesium Sulfate on Neuroprotection: A Meta-analysis Based on PRISMA Guidelines …

Abstract Objective: Magnesium sulfate (MgSO4) administered to women at risk for preterm
delivery decreases the risk of cerebral palsy in their children. However, the neuroprotective …

Objectives The use of magnesium sulfate (MgSO4) in European obstetric units is unknown.
We aimed to describe reported policies and actual use of MgSO4 in women delivering …

Maternal administration of magnesium sulfate (MS) has been associated with improved
neonatal survival and lower risk of cerebral palsy (CP). MS blocks the NMDA receptor, a …

Preterm delivery (PTD) is a major cause of neonatal morbidity and mortality, with surviving
infants at risk for long-term neurologic sequelae. Although any birth occurring before the …

Objective Magnesium historically has been used for treatment and/or prevention of
eclampsia or preterm labor. More recently, antepartum magnesium sulfate has been …